Carboplatin-based chemotherapy (C) versus immunotherapy (IO) in metastatic urothelial carcinoma (mUC).

被引：0

作者：

Feld, Emily

Harton, Joanna

Meropol, Neal J.

Adamson, Blythe J. S.

Parikh, Ravi Bharat

Galsky, Matt D.

Cohen, Aaron B.

Narayan, Vivek

Christodouleas, John Paul

Vaughn, David J.

Hubbard, Rebecca A.

Mamtani, Ronac

机构：

[1] Univ Pennsylvania, Philadelphia, PA USA

[2] Univ Pennsylvania, Perelman Sch Med, Dept Biostatist & Epidemiol, Philadelphia, PA USA

[3] Flatiron Hlth, New York, NY USA

[4] Tisch Canc Inst, Icahn Sch Med Mt Sinai, Dept Med, New York, NY USA

[5] Univ Pennsylvania, Dept Radiat Oncol, Philadelphia, PA USA

[6] Univ Pennsylvania, Perelman Sch Med, Ctr Clin Epidemiol & Biostatist, Philadelphia, PA USA

来源：

关键词：

D O I：

10.1200/JCO.2019.37.15_suppl.e16003

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

e16003

引用

页数：2